GC and osteoporosis: Patients with diabetic kidney disease exhibit an increased risk of osteoporosis attributable to decreased renal 25-hydroxyvitamin D-1α hydroxylase activity, enhanced urinary excretion of vitamin D-binding protein (VDBP) resulted from increased permeability of the glomerular filtration membrane, and imbalance in calcium and phosphorus metabolism in serum and bone (3).